- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
UP makes out case for central nod for pharma hub
Lucknow: In case all goes well, Uttar Pradesh could emerge as a manufacturing hub for pharmaceuticals in the country. Chief Minister Yogi Adityanath took the initiative in this regard by writing a letter to Union Minister for Chemicals and Fertilisers Sadanand Gowda around a month ago about the possibilities the northern state offers in this field.
Now, the state is awaiting the central government response on the matter.
India is at the third spot in drug manufacturing in the world. It is dependent on China for raw material/basic salts for certain drugs, ranging from 80 to 100 percent in certain cases.
Due to the coronavirus pandemic, global supply chains have been disrupted. Even the risk of importing such material has increased due to the pandemic.
NITI Aayog, Health Ministry and other departments concerned thus decided to make the country self-reliant in the field of drugs and medical equipment manufacturing, which in turn will be a fillip to the 'Make in India' initiative of the central government.
The Union Cabinet recently gave the nod for setting up four such parks across the country.
In his letter, the Chief Minister made out a case for Noida and Lucknow for setting up the proposed parks. He pointed out that four drug research labs were already situated in Lucknow while many drugs and medical equipment were already being manufactured in the state capital.
On the other hand, Noida is counted among the most developed industrial areas in the country. It will further receive a boost once the upcoming Jewar airport is completed, which will make exports easy.
"Since Prime Minister Narendra Modi wishes to make India a $5-trillion economy in the next five years, the state wants to become a $1-billion economy. Hence, Uttar Pradesh should be allotted four bulk drugs or medical equipment parks," Yogi Adityanath said in his letter.
MSME Principal Secretary Dr. Navneet Sehgal said: "The Centre is considering the pharma hub proposal. A detailed project report is being prepared. Uttar Pradesh is preparing a detailed report. We will begin work as soon as we get the green signal from the Centre."
It is pertinent to mention here that the states where these parks will be set up will be eligible for many relaxations/incentives from the Union government. The Centre will build solvent recovery plants, common effluent treatment plants, and drug testing labs in such parks.
Read also: Telangana: Bulk drug manufacturers operating at 50% capacity despite exemption
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751